We are Sorry, This Page doesn't Exist
Takeda To Expand Immuno-Oncology Portfolio With Maverick Therapeutics Acquisition
Takeda Pharmaceutical Co Ltd (NYSE: TAK) has read more.....»»
Amgen to buy Five Prime Therapeutics in a deal valued at $1.9 billion to boost cancer treatment portfolio
Amgen Inc. announced Thursday an agreement to buy biotechnology company Five Prime Therapeutics Inc......»»
Halozyme Therapeutics (HALO) Stock Is Absurdly Cheap Right Now
Artisan Mid Cap Fund recently released its Q1 2020 Investor Letter, a copy of which you can download below. The fund posted a return of -11.55.....»»
First Eagle Fund of America Comments on Halozyme Therapeutics
Guru stock highlightCheck out First Eagle Investment Stock Picks » Download GuruFolio Report of First Eagle Investment (Updated on 04/28/2020)Related Stocks: HALO,.....»»
Halozyme Therapeutics, Inc. (HALO): Are Hedge Funds Right About This Stock?
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We .....»»
Halozyme Therapeutics is Now Oversold (HALO)
Dividend Channel.....»»
Neos Therapeutics plans commercial launch of ADHD portfolio in Puerto Rico in Q2
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Halozyme Therapeutics Larger Than S&P 500 Component Under Armour
Market News Video.....»»
Halozyme Provides 2020 Business Update And Financial Guidance
SAN DIEGO, Jan. 14, 2020 /PRNewswire/ --Â Halozyme Therapeutics, Inc. (NASDAQ:HALO) today provided an update on its outlook for 2020, including financial guidance. "We have made tremendous progress repositioning the company to focus so.....»»
Halozyme Therapeutics upgraded to outperform from market perform at BMO Capital
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Halozyme Therapeutics stock price target raised to $24 from $17 at BMO Capital
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Halozyme Therapeutics Reaches Analyst Target Price
Dividend Channel.....»»
Biotech Stock On The Radar: Nabriva And Its Novel Antibiotic Portfolio
Nabriva Therapeutics PLC – ADR (NASDAQ: NBRV) share.....»»
Amarantus enters into agreement to license therapeutics portfolio to Emerald
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
is Halozyme Therapeutics, Inc. (HALO) Going To Burn These Hedge Funds?
Before we spend days researching a stock idea we like to take a look at how hedge funds and billionaire investors recently traded that stoc.....»»
Halozyme Therapeutics (HALO) Shares Cross Below 200 DMA
Market News Video.....»»
Merck buys Peloton to expand its kidney cancer treatment portfolio
U.S. drugmaker Merck & Co Inc on Tuesday agreed to buy Peloton Therapeutics Inc for $1.05 billion in cash, gaining access to the privately held company's lead kidney cancer drug candidate......»»
Turning Point Therapeutics IPO: What You Need To Know
When Turning Point Therapeutics hits the markets Wednesday, it wants to pivot your portfolio toward the rich field of oncology. read more.....»»
Denali Therapeutics Reports Full Year 2018 Financial Results and Business Highlights
SOUTH SAN FRANCISCO, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ:DNLI), a biopharmaceutical company developing a broad portfolio of p.....»»
GSK to transfer rare disease gene therapy portfolio to Orchard Therapeutics
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»